News & Press


#CUREOM Unite! – Thank You!

October 30, 2015

The results are in and #CUREOM Unite! was a tremendous success! Thank you to everyone who gave so generously to this campaign to further patient-centered ocular melanoma (OM) research! Dear Friends,   As of October 15, 2015, the #CUREOM Unite! cam …



FDA Approves First New Adjuvant Treatment for Stage III Melanoma Patients in 20 Years

October 27, 2015

Statement from Tim Turnham, Executive Director, Melanoma Research Foundation   Washington, D.C.—Today the Food and Drug Administration (FDA) approved ipilimumab (Yervoy) for use as a way to lower the risk of recurrence for melanoma patients …



FDA Approves Talimogene Laherparepvec (T-VEC) for Advanced Melanoma

October 27, 2015

Today the FDA approved Amgen’s drug, Imlygic (Talimogene Laherparepvec or T-VEC), for the treatment of unresectable Stage IIIB, IIIC or IV metastatic melanoma, bringing a novel immunotherapy to people with advanced melanoma, many of whom have limited t …



Guest Post: Dr. Richard Carvajal – #CUREOM Unite!

October 14, 2015

For the last decade, Dr. Richard Carvajal has dedicated his career to the research and treatment of rare cancers like ocular melanoma (OM) and understands the need for more funding to drive research breakthroughs in the field. Dr. Carvajal currently se …



Guest Post: Connie’s Story

October 6, 2015

Guest blogger Connie Popp shares her experience as an ocular melanoma caregiver, advocate and participant in Miles for Melanoma in support of the CURE OM Unite! campaign. My name is Connie Popp. On May 8, 2015, my husband Ted passed away after a 5 year …